Efficacy and safety of tocilizumab in european children with systemic onset juvenile idiopathic arthritis

por Nemiche, O, Dagner, R, Quartier, P, Cimaz, R, Richer, O, Pillet, P, Hofer, M
Publicado 2011

Interleukin-1 antagonists in Mevalonate Kinase Deficiency

por Galeotti, C, Rossi-Semerano, L, Guillaume, S, Duquesne, A, Pillet, P, Richer, O, Hachulla, E, Koné-Paut, I
Publicado 2011

PW03-019 – Survey of off-label ANTI-IL1 treatments in France

por Rossi-Semerano, L, Fautrel, B, Wendling, D, Hachulla, E, Meyer, A, Ottaviani, S, Galeotti, C, Fouillet-Desjonqueres, M, Richer, O, Touitou, I, Koné-Paut, I
Publicado 2013

PReS-FINAL-2228: Survey of off-label ANTI-IL1 treatments in France: two years data

por Rossi-Semerano, L, Fautrel, B, Wendling, D, Hachulla, E, Galeotti, C, Meyer, A, Ottaviani, S, Dhote, R, Richer, O, Fouillet-Desjonqueres, M, Touitou, I, Koné-Paut, I
Publicado 2013

Arthrite juvénile idiopathique et Covid-19 : impact de la pandémie sur le traitement et le retour à l’école

por Quéré, B., Lemelle, I., Lohse, A., Pillet, P., Molimard, J., Richer, O., Sordet, C., Despert, V., Rossi-Semerano, L., Borocco, C., Koné-Paut, I., Gervais, E., Guellec, D., Devauchelle Pensec, V.
Publicado 2021

Efficacy, safety and effect on gene expression profiling of anakinra in systemic-onset juvenile idiopathic arthritis: final results of a randomised, double-blind, placebo-controlle...

por Quartier, P, Allantaz, F, Cimaz, R, Pillet, P, Richer, O, Desjonqueres, M, Duquesne, A, Messiaen, C, Bardin, C, Bossuyit, X, Boutten, A, Bienvenu, J, Menoni, V, Sotou-Bere, S, Neven, B, Mahloui, N, Mogenet, A, Kassai, B, Chaussabel, D, Treluyer, JM, Bresson, JL, Landais, P, Pascual, V
Publicado 2008